| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
BRAF as therapeutic target in melanoma
|
Wellbrock, Claudia
|
|
2010
|
80 |
5 |
p. 561-567
7 p.
|
artikel
|
| 2 |
Building on a foundation of VEGF and mTOR targeted agents in renal cell carcinoma
|
Flaherty, Keith T.
|
|
2010
|
80 |
5 |
p. 638-646
9 p.
|
artikel
|
| 3 |
Current strategies to target p53 in cancer
|
Chen, Fang
|
|
2010
|
80 |
5 |
p. 724-730
7 p.
|
artikel
|
| 4 |
Development of small-molecule inhibitors of the group I p21-activated kinases, emerging therapeutic targets in cancer
|
Yi, Chunling
|
|
2010
|
80 |
5 |
p. 683-689
7 p.
|
artikel
|
| 5 |
Editorial Advisory Board
|
|
|
2010
|
80 |
5 |
p. iii-
1 p.
|
artikel
|
| 6 |
Exploiting the balance between life and death: Targeted cancer therapy and “oncogenic shock”
|
Sharma, Sreenath V.
|
|
2010
|
80 |
5 |
p. 666-673
8 p.
|
artikel
|
| 7 |
Exploring death receptor pathways as selective targets in cancer therapy
|
Russo, Maria
|
|
2010
|
80 |
5 |
p. 674-682
9 p.
|
artikel
|
| 8 |
Fine tuning chemotherapy to match BRCA1 status
|
Price, Melissa
|
|
2010
|
80 |
5 |
p. 647-653
7 p.
|
artikel
|
| 9 |
Graphical Abstracts Contents
|
|
|
2010
|
80 |
5 |
p. e1-e7
nvt p.
|
artikel
|
| 10 |
Identification of novel pancreatic adenocarcinoma cell-surface targets by gene expression profiling and tissue microarray
|
Morse, David L.
|
|
2010
|
80 |
5 |
p. 748-754
7 p.
|
artikel
|
| 11 |
Introduction to the Biochemical Pharmacology special issue on targeted cancer therapy
|
Smalley, Keiran S.M.
|
|
2010
|
80 |
5 |
p. 549-
1 p.
|
artikel
|
| 12 |
Methods for investigation of targeted kinase inhibitor therapy using chemical proteomics and phosphorylation profiling
|
Fang, Bin
|
|
2010
|
80 |
5 |
p. 739-747
9 p.
|
artikel
|
| 13 |
Molecular imaging and targeted therapies
|
Morse, David L.
|
|
2010
|
80 |
5 |
p. 731-738
8 p.
|
artikel
|
| 14 |
Molecularly targeted therapy in hepatocellular carcinoma
|
Huynh, Hung
|
|
2010
|
80 |
5 |
p. 550-560
11 p.
|
artikel
|
| 15 |
Notch signaling: Emerging molecular targets for cancer therapy
|
Yin, Ling
|
|
2010
|
80 |
5 |
p. 690-701
12 p.
|
artikel
|
| 16 |
Potential therapeutic implications of cancer stem cells in glioblastoma
|
Cheng, Lin
|
|
2010
|
80 |
5 |
p. 654-665
12 p.
|
artikel
|
| 17 |
Small molecule modulation of HH-GLI signaling: Current leads, trials and tribulations
|
Mas, Christophe
|
|
2010
|
80 |
5 |
p. 712-723
12 p.
|
artikel
|
| 18 |
Striking the target in Wnt-y conditions: Intervening in Wnt signaling during cancer progression
|
Camilli, Tura C.
|
|
2010
|
80 |
5 |
p. 702-711
10 p.
|
artikel
|
| 19 |
Targeted therapies of gastrointestinal stromal tumors (GIST)—The next frontiers
|
Duensing, Stefan
|
|
2010
|
80 |
5 |
p. 575-583
9 p.
|
artikel
|
| 20 |
Targeted therapy of chronic myeloid leukemia
|
Sullivan, Con
|
|
2010
|
80 |
5 |
p. 584-591
8 p.
|
artikel
|
| 21 |
Targeted therapy of thyroid cancer
|
Sherman, Steven I.
|
|
2010
|
80 |
5 |
p. 592-601
10 p.
|
artikel
|
| 22 |
Targeting epidermal growth factor receptor: Central signaling kinase in lung cancer
|
Yoshida, Takeshi
|
|
2010
|
80 |
5 |
p. 613-623
11 p.
|
artikel
|
| 23 |
Targeting KIT in melanoma: A paradigm of molecular medicine and targeted therapeutics
|
Woodman, Scott E.
|
|
2010
|
80 |
5 |
p. 568-574
7 p.
|
artikel
|
| 24 |
Targeting the MAPK pathway in melanoma: Why some approaches succeed and other fail
|
Inamdar, Gajanan S.
|
|
2010
|
80 |
5 |
p. 624-637
14 p.
|
artikel
|
| 25 |
The benefits and challenges associated with the use of drug delivery systems in cancer therapy
|
Cukierman, Edna
|
|
2010
|
80 |
5 |
p. 762-770
9 p.
|
artikel
|
| 26 |
The bone marrow microenvironment as a sanctuary for minimal residual disease in CML
|
Nair, Rajesh R.
|
|
2010
|
80 |
5 |
p. 602-612
11 p.
|
artikel
|
| 27 |
Using genetics and genomics strategies to personalize therapy for cancer: Focus on melanoma
|
Nathanson, Katherine L.
|
|
2010
|
80 |
5 |
p. 755-761
7 p.
|
artikel
|
Tijdschrift beschrijving